Boston, MA -- (SBWIRE) -- 12/20/2013 -- At winstonsmallcap.com we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. Let have a Look on: North American Palladium Ltd (USA )(NYSEMKT:PAL), LUKOIL (ADR)(OTCMKTS:LUKOY), BlackBerry Ltd(NASDAQ:BBRY), Arena Pharmaceuticals, Inc.(NASDAQ:ARNA).
North American Palladium Ltd (USA )(NYSEMKT:PAL) opened its shares at the price of $0.47 for the day. Its closing price was $0.470. The company traded with the total volume of 1.80 million shares, while its average trading volume remained 2.78 million shares. The beta of PAL stands at 2.31. North American Palladium Ltd. (NAP) is a precious metals producer that has been operating its flagship Lac des Iles mine (LDI) located in Ontario, Canada. LDI is a primary producer of palladium.
Can Investors Bet on PAL after this News update? Find out in this Research Report
LUKOIL (ADR)(OTCMKTS:LUKOY) change plunged -0.53% to close at $61.85 with the total traded volume of 189,579 shares, and average volume of 111,102. The 52 week range of the stock remained $54.20 - $67.80, while its day lowest price was $61.65 and it hit its day highest price at $62.25. NK Lukoil OAO (Neftyanaya Kompaniya LUKOIL OAO or NK LUKOIL OJSC) is a Russia-based integrated oil and gas company. The Company is engaged in the business of oil exploration, production, refining, marketing and distribution.
Has LUKOY Found The Bottom And Ready To Gain Momentum? Find Out Here
BlackBerry Ltd(NASDAQ:BBRY) started its trading session with the price of $6.08 and closed at $6.25 by scoring +3.14%. BBRY stocks traded with total volume of 14.97 million shares, while the average trading volume remained 13.94 million shares. The beta of BBRY stands at 1.39. Day range of the stock was $6.05 -$6.26. BlackBerry Limited, formerly Research In Motion Limited is a designer, manufacturer and marketer of wireless solutions for the worldwide mobile communications market. Through the development of integrated hardware, software and services, it provides platforms and solutions for seamless access to information, including e-mail, voice, instant messaging, short message service (SMS), Internet and intranet-based applications and browsing.
Will BBRY Continue To Move Higher? Find Out Here
Arena Pharmaceuticals, Inc.(NASDAQ:ARNA) ended its day with the gain of +0.36% and closed at the price of $5.60 after opening at $5.56. Stock traded during its last trading session with the total volume of 3.33 million shares, as compared to its average volume of 5.61 million shares. Arena Pharmaceuticals, Inc. (Arena) is a biopharmaceutical company focused on discovering, developing and commercializing drugs that target G protein-coupled receptors. Its wholly owned subsidiary, Arena Pharmaceuticals GmbH (Arena GmbH), has granted Eisai Inc., rights to commercialize BELVIQ in the United States.
Why Should Investors Buy ARNA After The Recent Gain? Just Go Here and Find Out
Here at Winston we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. We focus on companies that we feel are trading at a discount to the market for various reasons. Enter your email and track our performance! We are sure you won’t be disappointed.
http://winstonsmallcap.com/ and its owners, and their affiliates, directors and officers, and immediate family members, are hereafter collectively referred to as “WSC” or “we” or “us” or “our”). WSC publishes information (the “Information”) about publicly traded companies (the “Profiled Company” or the “Profiled Companies”) which has been obtained from various sources including publicly available sources on the internet. WSC does not undertake any due diligence or investigation of the Information it obtains or publishes.
Read Full Disclaimer at: http://winstonsmallcap.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)